Mounjaro Injection: A Complete Guide to the Once-Weekly Tirzepatide Pen

Mounjaro injection is a once-weekly prescription pen that delivers tirzepatide under the skin to help lower blood sugar in adults with type 2 diabetes. The same drug is sold as Zepbound injection for chronic weight management, and both products are made by Eli Lilly. It is not a muscle or vein injection, it is not a cure, and it works best alongside diet, movement, and regular medical care.

What the Mounjaro Injection Is Used For

Mounjaro is FDA-approved to improve blood sugar in adults with type 2 diabetes, used together with diet and exercise. Zepbound contains the same active ingredient and is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition.

Many people search for Mounjaro injection for weight loss, and that request is fairly common in practice. Mounjaro is not FDA-approved for weight loss, so any weight-loss use of the Mounjaro brand is off-label, and insurance coverage often depends on the diagnosis written on the prescription.

Tirzepatide is the active ingredient in both Mounjaro and Zepbound, so the main difference is the approved indication and the label, not the molecule.

Feature	Mounjaro	Zepbound
Active ingredient	Tirzepatide	Tirzepatide
FDA-approved use	Type 2 diabetes	Chronic weight management
Starting dose	2.5 mg weekly	2.5 mg weekly
Maximum dose	15 mg weekly	15 mg weekly
How it is supplied	Single-dose pen, 4 per carton	Single-dose pen or multi-dose vial
Manufacturer	Eli Lilly	Eli Lilly

How the Injection Works in the Body

Tirzepatide activates two gut-hormone receptors at the same time: GIP and GLP-1. That dual action slows how quickly the stomach empties, increases feelings of fullness, and prompts the pancreas to release insulin when blood sugar runs high.

Delivery route shapes how any medicine behaves in the body. Discussions such as pt-141 nasal spray vs injection show that the same molecule can be absorbed, dosed, and tolerated differently depending on whether it enters through the nose or under the skin. Mounjaro is designed only for subcutaneous injection.

How to Use the Mounjaro 4 Dose Pen

Each carton holds four single-dose pens, which covers one dose per week for a month. There is nothing to measure, mix, or draw up, so learning how to use Mounjaro 4 dose pen packaging mostly means learning the device itself.

1. Wash your hands and set out an alcohol swab and a sharps container.
2. Check the medicine through the window: it should be clear and colorless to slightly yellow. Do not use a pen that looks cloudy, discolored, or contains particles.
3. Confirm the dose printed on the pen label and check the expiration date.
4. Pick a spot on your abdomen, thigh, or upper arm, clean the skin with the alcohol swab, and let it dry.
5. Twist off the base cap, press the flat end of the pen firmly against the skin, unlock it, and press and hold the dose button for 10 seconds. You should hear two clicks.
6. Pull the pen straight out, confirm the gray plunger is visible, and place the pen in a sharps container.

Rotate the injection site each week to limit irritation, and never inject into a vein or a muscle. Do not share a pen with another person, even if the needle is changed.

If you learn better by watching, Eli Lilly publishes an official Mounjaro injection video that demonstrates the same steps, and most pharmacies will walk you through your first dose in person. Device mechanics still differ: the vyleesi injection auto-injector hides its needle and fires with a single push, while a Mounjaro pen stays against your skin for the full 10-second count.

Dosing and Titration Schedule

Mounjaro is started low and raised slowly to reduce stomach side effects. The 2.5 mg starting dose is not intended to control blood sugar by itself; it is a tolerated introduction to the drug.

Weeks of treatment	Typical weekly dose
1 to 4	2.5 mg
5 to 8	5 mg
9 to 12	7.5 mg, if needed
13 to 16	10 mg, if needed
17 to 20	12.5 mg, if needed
21 and beyond	15 mg maximum

Dose increases should not happen more often than every four weeks. If you miss a dose, take it within four days of your scheduled day; if more than four days have passed, skip that dose and resume your normal weekly schedule. Never take two doses within three days of each other, and never split or reuse a single-dose pen.

Side Effects and Safety Warnings

The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, injection-site reactions, fatigue, and burping. These often ease as the dose stabilizes, but persistent vomiting or severe abdominal pain needs medical attention.

• Boxed warning: thyroid C-cell tumors seen in rodents; contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2.
• Pancreatitis and gallbladder disease: severe upper abdominal pain may signal either problem.
• Low blood sugar: risk rises when Mounjaro is combined with insulin or sulfonylureas.
• Kidney injury: dehydration from vomiting or diarrhea can strain the kidneys.
• Delayed gastric emptying: this can raise aspiration risk during anesthesia, so tell your care team before any procedure.

Mounjaro injection is a prescription medicine, and dosing decisions belong with a clinician who knows your history and current medications. Report new or worsening symptoms instead of adjusting your dose on your own, and ask a healthcare professional before starting or stopping any injectable diabetes or weight-loss product.

Compounded Tirz Shots vs Brand-Name Pens

The shorthand tirz injection or tirz shot usually refers to compounded tirzepatide sold by a compounding pharmacy, not brand-name Mounjaro. Compounded drugs are not FDA-approved, and the FDA removed tirzepatide from its shortage list in late 2024, which sharply limited when large-scale compounding is permitted.

Mounjaro pens arrive pre-filled and ready to use, so there is no powder to dissolve and no bacteriostatic water for injection required. That is different from lyophilized peptides, which are typically reconstituted with a diluent such as Hospira bacteriostatic water for injection before a dose is drawn into a syringe.

For the same reason, a 30ml bacteriostatic water for injection bottle belongs to the world of dry-powder vials rather than single-dose pens. Anyone comparing a brand-name pen with a compounded vial should confirm who made the product, whether it is FDA-approved, and exactly how the dose is measured.

COMMON QUESTIONS

Frequently Asked Questions

Is Mounjaro the same as Zepbound?

Both products contain tirzepatide and are made by Eli Lilly, but they carry different FDA approvals. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management. The pens and dose strengths are similar, though labeling, insurance coverage, and prescribing criteria differ.

Where do you inject Mounjaro?

Mounjaro is injected under the skin of the abdomen, thigh, or upper arm, using a new single-dose pen each week. Rotate the site with every dose to reduce irritation, and avoid injecting into a vein or muscle. Do not share a pen with anyone else.

How much weight can you lose on Mounjaro injection?

In clinical trials of tirzepatide, adults without diabetes lost roughly 21% of their body weight on the 15 mg dose over 72 weeks, but individual results vary widely. Mounjaro itself is not FDA-approved for weight loss, so a clinician would need to decide whether that use is appropriate for you and how to monitor it safely.